Dr. Anthony Fauci to give likely final Covid briefing as top White House health official

Dr. Anthony Fauci to give likely final Covid briefing as top White House health official


NIH National Institute of Allergy and Infectious Diseases Director Anthony Fauci addresses the daily press briefing at the White House in Washington, January 21, 2021.

Jonathan Ernst | Reuters

Dr. Anthony Fauci on Tuesday will give what is expected to be his last public briefing on the Covid-19 pandemic as the White House chief medical advisor.

Fauci announced earlier this year that he will step down in December after serving as the public face of the United States’ coronavirus pandemic response for more than two years.

He will give an update alongside Dr. Ashish Jha, head of the White House Covid task force. They are expected to encourage people to get their Covid boosters and flu shots as soon as possible.

Public health officials have repeatedly warned that the U.S. will likely face another wave of Covid this winter as people travel and gather for the holidays.

CNBC Health & Science

Read CNBC’s latest global health coverage:

The new boosters, which target the variant omicron BA.5, were quickly rolled out in an effort to head off a major surge. But only about 11% of those people eligible have received their shot so far.

The U.S. already facing a severe flu season, with hospitalizations at a decade high.

And respiratory syncytial virus, or RSV, is also hospitalizing children at a much higher rate than in pre-pandemic seasons.

Hospitals and emergency departments are increasingly taxed by people seeking treatment for respiratory illnesses.

Children’s hospitals last week called on the Biden administration to declare a public health emergency to provide more flexibility to address the surge of patients.



Source

Eli Lilly investors shouldn’t sweat rival Novo Nordisk having the first obesity pill on sale
Health

Eli Lilly investors shouldn’t sweat rival Novo Nordisk having the first obesity pill on sale

Jim Cramer says don’t sweat Novo Nordisk’s head start over Club holding Eli Lilly in the obesity pill market. Eli Lilly stock slipped about half a percent this morning, while Novo Nordisk shares surged more than 8% after becoming the first to secure FDA approval for a GLP-1 weight-loss pill. “[Novo] got approval ahead of […]

Read More
FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk
Health

FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk

The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts of Copenhagen, Denmark, Nov. 24, 2025. Tom Little | Reuters The U.S. Food and Drug Administration on Monday approved the first-ever GLP-1 pill for obesity from Wegovy maker Novo Nordisk, a landmark decision that health experts […]

Read More
UnitedHealth Group commits to improvements after independent audit, patient backlash
Health

UnitedHealth Group commits to improvements after independent audit, patient backlash

UnitedHealthcare sign is displayed at its office building in Minnetonka, Minnesota, U.S., Dec. 11, 2025. Tim Evans | Reuters UnitedHealth Group on Friday released the first results from a sprawling independent audit of its business practices and committed to a wide range of steps to track and implement improvements in three specific areas. The health-care […]

Read More